LBO — ASPIRUS WAUSAU HOSPITAL
IRR: 27.8% | MOIC: 3.41x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
27.8%
IRR
3.41x
MOIC
$207.0M
Entry EV
$463.0M
Exit EV
$106.5M
Equity Invested
Sources & Uses
S&UTotal · $207.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $80.4M | 38.8% | |
| Sub Debt | $20.1M | 9.7% | |
| Equity | $106.5M | 51.5% | |
| Enterprise Value | $201.0M | 97.1% | |
| Transaction Fees | $6.0M | 2.9% | |
| Total Uses | $207.0M | 100.0% |
Interpretation
INTAt 3.41x MOIC and 27.8% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $44.1M |
| Exit Ev | $463.0M |
| Net Debt At Exit | $99.5M |
| Equity At Exit | $363.5M |
| Equity Invested | $106.5M |
| Total Value Created | $257.0M |
| Value From Growth | $252.0M |
| Value From Multiple | $10.0M |
| Value From Deleveraging | $1.0M |